Corvus Pharmaceuticals Financial Overview
Corvus Pharmaceuticals's market cap is currently $647.49M. The company's EPS TTM is $-0.12; its P/E ratio is ―; Corvus Pharmaceuticals is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
